Clinical Study
Predisposing Factors for Deep Venous Thrombosis in Children and Adolescents with Nephrotic Syndrome
Table 2
Results of the variable analysis between the “with DVT” and “without DVT” groups.
| Variable | “With DVT”
| “Without DVT”
| P value |
| Hemoglobin (g/dL) | | | 0.3 | Hematocrit (%) | | | 0.05 | Prednisone dose/weight (mg/kg) | | | 0.657 | Total cholesterol (mg/dL) | | | 0.074 | Triglycerides (mg/dL) | | | 0.008 | HDL (mg/dL) | | | 0.225 | Platelet number (mm3) | | | 0.507 | Albumin (g/dL) | | | 0.959 | Serum creatinine (mg/dL) | | | 0.959 | Weight gain during hospitalization (%) | | | 0.248 |
| | n (%) | n (%) | |
| History of dehydration | 3 (27%) | 0 (0%) | 0.107 | Use of spironolactone | 6 (55%) | 5 (45%) | 0.5 | Use of furosemide | 0% | 3 (27%) | 0.107 | Use of another immunosuppressant | 2 (18%) | 2 (18%) | 0.707 | Use of ASA | 2 (18%) | 1 (9%) | 0.5 | Trauma | 0 (0%) | 0 (0%) | — | Infection or severe systemic event | 9 (81%) | 3 (27%) | 0.015 |
|
|
M: mean; SD: standard deviation; ASA: acetylsalicylic acid.
|